Percutaneous intervention for infrageniculate arterial disease in women may be associated with better outcomes when compared to men  by Tye, Andrew et al.
From the Society for Vascular Surgery
Percutaneous intervention for infrageniculate
arterial disease in women may be associated with
better outcomes when compared to men
Andrew Tye, BA, Daniel K. Han, MD, Rami O. Tadros, MD, Constantinos T. Spyris, BA,
Victoria Teodorescu, MD, Michael L. Marin, MD, Peter L. Faries, MD, and Ageliki G. Vouyouka, MD,
New York, NY
Objective: The purpose of this study was to identify any gender-associated differences in the percutaneous treatment of
infrageniculate lesions in individuals with chronic critical limb ischemia.
Methods: A retrospective chart review was performed on 112 index tibial lesions in 81 consecutive patients operated on
from January 2005 to February 2011. All patients were treated for critical limb ischemia—defined as rest pain or tissue
loss. Patient demographics, comorbidities, clinical presentation, vascular studies, lesion characteristics, procedures, and
postoperative complications were entered into a database for review. Patients were evaluated for primary patency,
secondary patency, limb salvage, and mortality rates.
Results: Sixty-three index tibial lesions were treated percutaneously in 43 women, compared to 49 lesions in 38 men.
There was a trend toward increased cardiac disease (65.8% men vs 44.2% women; P  .052) and smoking (52.6% men vs
32.6% women; P  .070) in men. Men were more likely than women to have TransAtlantic Inter-Society Consensus
(TASC) C and D lesions (83.7% vs 65.1%; P  .023) and to be treated for total occlusion (44.9% vs 25.4%; P  .031).
There were no significant gender-related differences in length of stay or postoperative complications. Women had
statistically better primary patency rates than men at 12 and 24 months (77.5%  6.9% and 72.9%  7.8% in women vs
58.7% 9.3% and 45.2% 9.9% in men; P .032). Women also had statistically better secondary patency rates than men
at 12 and 24 months (90.4% 4.8% and 85.1% 6.8% in women vs 76.0% 8.1% and 58.5% 10.8% in men; P .028).
Female gender remained an independent predictor of superior patency even after controlling for gender-related
differences in TASC grade. There were no significant differences in limb salvage rates at 12 and 24 months (92.1% 4.4%
and 85.0%  7.9% in women vs 88.3%  6.4% and 83.4%  7.7% in men; P  .985). Overall survival rates were similar
(59.8%  7.6% for women and 68.0%  8.1% for men at 24 months; P  .351).
Conclusions: Percutaneous intervention may be an equally effective or better treatment option for women with chronic
limb ischemia and tibial disease when compared to men. In this study, male gender was an independent predictor of
poorer primary and secondary patency rates after infrageniculate intervention. There were no differences in postoperative
wound complications between genders. Endovascular procedures may lessen the gap in gender-related treatment
outcomes and postoperative complications seen after open arterial reconstructions. ( J Vasc Surg 2013;57:706-13.)
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mLower extremity peripheral arterial disease (PAD) af-
flicts 8 million people in the United States and is directly
associated with increased functional impairment, increased
adverse cardiovascular events, and decreased quality of life.1
Although PAD was once regarded as a male-dominant
disease, recent literature has revealed that the disease is
equally prevalent in elderly men and women.2 Previous
studies have shown that women tend to be diagnosed with
PAD at a later age and with more advanced disease, and are
less likely to have comorbid coronary and cerebrovascular
disease.3-5 Even further, recent studies have shown that
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706omenwith PAD experience a significantly faster decline in
unctioning and mobility than men with PAD.6
Gender-related differences in the presentation of PAD
re also associated with differences in risk factors, manage-
ent, and outcomes. For example, prior research has sug-
ested that female gender is associated with increased rates
f postoperative infection and wound complications after
ower extremity open surgical bypass. Historical trials com-
aring outcomes between genders after open arterial recon-
tructions have yielded conflicting results when it comes to
atency and limb salvage rates.7-13 However, as vascular
nterventions evolve and treatment paradigms change, the
anagement of lower extremity PAD, including tibial dis-
ase, has moved away from open surgical bypass and toward
ess invasive procedures that are traditionally associated
ith decreased wound complications.14-17 One recent
tudy performed by our group confirmed this trend in
omen by using state inpatient discharge databases from
ew York, New Jersey, and Florida. Although women with
ower extremity PAD in that study were less likely than their
ale counterparts to undergo open revascularization, rates
f endovascular reintervention were equivalent in men and
b
n
o
f
i
u
t
0
t
w
w
u
Q
C
f
u
T
m
a
p
p
n
A
i
t
w
l
g
t
r
p
b
d
t
3
t
i
u
f
o
a
e
f
r
d
p
v
t
d
d
t
a
r
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 3 Tye et al 707women, increased over time, and were associated with less
gender-related differences in mortality and morbidity when
compared to open procedures.18 In another study, the
authors specifically examined the role of gender on the
immediate and long-term outcomes of percutaneous treat-
ment of infrainguinal occlusive disease; women were found
to have equivalent rates of patency, limb salvage, and
postoperative complications as men, despite more ad-
vanced disease upon presentation.19 These results have
confirmed similar observations made by Abando et al.20
Nonetheless, there is scarce literature examining the effects
of endovascular treatment for infrageniculate disease in
women. The purpose of this study was to identify any
gender-associated differences in the percutaneous treat-
ment of infrageniculate lesions, specifically relating to de-
mographics, disease presentation, postoperative complica-
tions, and treatment outcomes.
METHODS
Study design. From January 2005 to February
2011, 302 consecutive patients undergoing endovascu-
lar procedures were included in a prospectively main-
tained computerized database. Information regarding
patient demographics, comorbidities, clinical presenta-
tion, vascular studies, lesion characteristics, procedures
performed, and postoperative complications were re-
corded. Follow-up data were also recorded for subse-
quent hospital, office, and vascular laboratory visits.
Only patients requiring treatment for chronic critical
limb ischemia (rest pain or tissue loss) were included;
patients requiring emergent intervention for acute isch-
emia were excluded from this study. These data did not
incorporate unsuccessful attempts at tibial revasculariza-
tion. Chronic renal insufficiency was defined as a sus-
tained increase in serum creatinine marked by two sepa-
rate serum creatinine readings greater than or equal to
1.5 separated by 3 months. Balloon and stent length and
diameter were assessed as indicators of vessel length and
diameter. In total, 87 procedures were performed for
index tibial lesions. This series includes patients under-
going isolated treatment of index tibial lesions as well as
those being treated for concurrent femoral or popliteal
lesions. Gender differences in outcomes for infragenicu-
late interventions were assessed.
Methodology. All endovascular procedures were per-
formed by vascular interventionalists using fixed fluoro-
scopic equipment or a portable imaging fluoroscopic C-
arm. The type of procedure performed, which included
angioplasty with or without stent placement, was left to the
discretion of the interventionalist. Procedures were per-
formed with the patient under local anesthesia with intra-
venous sedation or under general anesthesia according to
the patient’s overall condition and the interventionalist’s
discretion. Selective angiography was performed to localize
target lesions and plan necessary interventions. Iodinated
contrast was used for most of the patients. Dosage and
dilution was tailored according to procedure and the pa-
tient’s renal status. A few patients received gadolinium aefore the release of the “black box” warnings relating to
ephrogenic systemic fibrosis.
Femoral artery access was gained through an antegrade
r retrograde approach. Antegrade punctures were per-
ormed with short 4 to 8F sheaths whereas contralateral
nterventions performed through a retrograde puncture
sed long 4 to 8F sheaths. Lesions were crossed through
he native lumen or subintimally using 0.035, 0.018, or
.014-inch guidewires in various combinations in conjunc-
ion with guide catheters. Subintimal crossing of lesions
as used in all total occlusions. Typically, 0.014-inch wires
ere used to cross tibial lesions. The wires were supported
sing a 4F or 5F angled Glide catheter (Angiodynamics,
ueensbury, NY) or Quick cross catheter (Spectranetics,
olorado Springs, Colo). After sheath placement and be-
ore any intervention, patients were routinely heparinized
sing a bolus of 80 to 100 units/kg of intravenous heparin.
he activated clotting time was checked every 30 to 60
inutes. Heparin was re-dosed as needed to maintain an
ctivated clotting time above 300 seconds throughout the
rocedures.
Balloon angioplasty was performed by inflation of ap-
ropriately sized, usually 2 to 4 mm in diameter, long,
oncompliant balloons for 60 to 180 seconds at 6 to 15
TM of pressure with gradual dilatation of the artery up to
ts normal size as determined by measuring the diameter of
he adjacent patent arterial segment. Provisional stenting
as used for lesions with 30% residual stenosis, flow-
imiting dissections, or for vessel recoil. Completion an-
iography was performed after all interventions. All pa-
ients without contraindications for antiplatelet therapy
eceived aspirin and clopidogrel. For clopidogrel naive
atients, 75 mg of clopidogrel was started at least 5 days
efore a planned procedure or 300 to 450 mg of clopi-
ogrel was given immediately after an intervention. Pa-
ients were maintained with 75 mg of clopidogrel daily for
0 days. After 30 days, the need for dual antiplatelet
herapy was reassessed. If tolerated, aspirin was continued
ndefinitely.
Determination of patency. Follow-up for patients
ndergoing endovascular procedures was routinely per-
ormed with duplex ultrasound scan every 3 months post-
peratively (eg, 3, 6, 9, and 12 months) for the first year
nd annually thereafter. The entire length of all tibial vess-
ls was routinely imaged by duplex scans during each
ollow-up visit. Hospital, office, and vascular laboratory
ecords were reviewed to obtain anatomic follow-up data to
etermine primary and secondary patency rates. Loss of
atency was defined as occlusion or critical stenosis with
elocity ratio greater than 2.5:1 (representing a greater
han 50% reduction in the lumen diameter) on arterial
uplex scan. Computed tomographic angiography and/or
igital subtraction angiography were performed to confirm
he lesion before reintervention.
Statistical analysis. Demographics, comorbidities,
nd mortality rates were assessed by patient, patency
ates and lesion characteristics were assessed by lesion,
nd postoperative complications were reported by in-
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March 2013708 Tye et altervention. Kaplan-Meier survival curves were used to
analyze patency, limb salvage, and mortality rates, and
comparison of Kaplan-Meier curves was performed by
log-rank analysis. Univariate analysis of dichotomous
variables between genders was performed by Fisher exact
t-test. Values were expressed as a mean  SD, where
applicable, and significance was assumed for P values less
than .05. Statistical analysis of the prospectively collected
data was performed with SPSS 17.0 software (SPSS,
Chicago, Ill).
RESULTS
Patient demographics and comorbidities. From
January 2005 to February 2011, a total of 63 index tibial
lesions were treated percutaneously in 43 female patients,
compared to 49 index tibial lesions in 38 male patients.
Demographics and comorbidities are stratified by gender in
Table I. In our study, women tended to present for treat-
ment at a later age than men, although this difference did
not reach significance (72.53 years in women, 68.47 years
in men; P  .139). Additionally, men in our study had a
trend toward increased prevalence of smoking (52.6% of
men vs 32.6% of women; P  .070) and cardiac disease
(65.8% of men vs 44.2% of women; P  .052), although
neither of these patterns reached significance.
Presentation, lesion distribution, and treatment
modality. Presentation, lesion distribution, and treatment
modality are shown in Tables II and III. Generally, men
were more likely to be treated for vessel occlusion (vs
stenosis) than women (44.9% vs 25.4%; P  .031). Addi-
tionally, men had statistically more severe TransAtlantic
Inter-Society Consensus (TASC)-graded disease, as 83.7%
of men had TASCC andD lesions as compared to 65.1% of
women (P  .023). There were no gender-related dif-
ferences in lesion diameter (3.05  0.521 mm in women
vs 3.00  0.479 mm in men; P  .735) or lesion length
(68.81 65.38mm in women vs 64.30 63.48 in men;
Table I. Demographics and comorbidities in men and
women undergoing percutaneous infra-geniculate
interventions
Women Men
P valueNo. (%) No. (%)
Total 43 38
Age (years) 72.53 68.47 .139
Diabetes 29 (67.4) 29 (76.3) .383
Chronic renal insufficiency 11 (25.6) 8 (21.1) .636
End-stage renal disease
(HD)
10 (23.3) 11 (28.9) .565
Hypertension 37 (86.0) 32 (84.2) .819
Cardiac disease 19 (44.2) 25 (65.8) .052
Chronic obstructive
pulmonary disease 6 (14.0) 3 (7.9) .393
Cancer 6 (14.0) 4 (10.5) .645
Smoking 14 (32.6) 20 (52.6) .070
HD, Hemodialysis.P  .773). There were no gender-related differences in greoperative ankle-brachial indexes (0.83  0.497 in
omen vs 0.76 0.470 inmen; P .722) or postoperative
nkle-brachial indexes (0.93  0.359 in women vs 0.89 
.264 in men; P .792). All men and women were treated
or either rest pain or tissue loss and were grouped accord-
ng to the Fontaine classification for chronic limb ischemia,
hich revealed no gender-related differences. Of the infra-
able II. Presentation and lesion severity in primary
nterventions in men and women
Women Men
P valueNo. (%) No. (%)
ontaine classification
Stage 3 12 (26.1) 10 (24.4) .856
Stage 4 34 (73.9) 31 (75.6)
ASC I classification
TASC A and B 22 (35.0) 8 (16.3) .023
TASC C and D 41 (65.1) 41 (83.7)
esion
cclusion 16 (25.4) 22 (44.9) .031
tenosis 47 (74.6) 27 (55.1)
ASC, TransAtlantic Inter-Society Consensus.
he boldface numbers represent statistical significance (P .05).
able III. Lesion distribution and treatment modality
Women Men
P valueNo. (%) No. (%)
egions treated
Tibial only 16 (34.8) 14 (34.1) .418
Tibial and femoral 3 (6.5) 3 (7.3)
Tibial and popliteal 3 (6.5) 8 (19.5)
Tibial and femoral
and popliteal 22 (47.8) 14 (34.1)
Other 2 (4.3) 2 (4.9)
ibial vessels treated
Posterior tibial 7 (11.1) 14 (28.6) .119
Tibioperoneal trunk 16 (25.4) 10 (20.4)
Anterior tibial 26 (41.3) 18 (36.7)
Peroneal 14 (22.2) 7 (14.3)
reatment modality
Angioplasty alone 46 (73.0) 38 (77.6) .621
Angioplasty with
stenting 16 (25.4) 11 (22.4)
Atherectomy 1 (1.6) 0 (0)
able IV. Postoperative complications
Women Men
P valueNo. (%) No. (%)
ematoma requiring
intervention 1 (2.2) 2 (4.9) .496
seudoaneurysm 3 (6.5) 2 (4.9) .746
hrombosis 1 (2.2) 0 (0.0) .348
cute cardiac event 0 (0.0) 0 (0.0) 1
eturn to operating room
within 30 days 2 (4.3) 5 (12.2) .196
eath within 30 days 0 (0.0) 1 (2.4) .323eniculate procedures performed in women, 34.8% were
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Volume 57, Number 3 Tye et al 709for isolated tibial lesions whereas the remaining 65.2% were
for tibial and concurrent iliac, femoral, or popliteal disease.
These rates were similar to those in men (34.1% with
isolated tibial lesions, 65.9% with tibial and concurrent
iliac, femoral, or popliteal disease; P  .418). There were
22 women (47.8% of all lesions) and 14 men (34.1% of
lesions) that had concomitant femoropopliteal interven-
tions, with no significant difference between genders (Ta-
ble III). There were no significant differences between
genders in the particular tibial vessels that were treated.
Treatment modalities were also consistent between gen-
ders, as rates of angioplasty alone vs angioplasty with stent-
ing vs atherectomy were similar in men and women.
Outcomes. Patients were reviewed for postoperative
development of hematoma requiring intervention, pseudo-
aneurysm, access site thrombosis, acute cardiac event, and
death. Acute cardiac event was defined as the postoperative
development of one or more of the following: myocardial
infarction, electrocardiographic changes, new arrhythmia,
or congestive heart failure. Two men developed hemato-
mata requiring reintervention, whereas one woman devel-
oped this complication (4.9% vs 2.2%; P  .496). In the
study, there was one patient death in the perioperative
period due to a retroperitoneal hematoma, leading to a
30-day mortality of 2.4% for men and 0% for women (P 
.324). All other complication rates, including return to
operating room within 30 days and length of stay, were
not significantly different between genders as shown in
Table IV.
Mean and median follow-up time for all lesions was
13.08 and 7.4 months, respectively, with SD and range of
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Fig 1. Primary patency rates for infrageniculate interven
and 24-month primary patency rates for women were 77
and 45.2%  9.9% in men (P  .032).14.78 and 70 months, respectively. Duplex scan follow-up fas performed at 3, 6, 9, and 12 months and compliance
ates were 76.8%, 64.3%, 53.6%, and 48.2%, respectively.
he 12- and 24-month primary patency rates for women
ere 77.5%  6.9% and 72.9%  7.8%, compared with
8.7%  9.3% and 45.2%  9.9% in men. This difference
as found to be statistically significant when analyzed by
og-rank analysis of Kaplan-Meier distributions, as shown in
ig 1 (P  .032). Gender remained an independent pre-
ictor of primary patency rate even after TASC grade
ifferences were accounted for using Cox proportional
azards model with gender and TASC grade as covariates
Table V). The 12- and 24-month secondary patency rates
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HR 95% CI P value
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Gender 0.395 0.175-0.891 .025
TASC A and B vs
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patency failure
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I, Confidence interval; HR, hazard ratio; TASC, TransAtlantic Inter-
ociety Consensus.
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March 2013710 Tye et alpared with 76.0% 8.1% and 58.5% 10.8% in men. This
difference was also statistically significant as demonstrated
in Fig 2 (P .028), and gender remained an independent
predictor of secondary patency rate even after TASC
grade was controlled (Table V). The number of repeat
interventions did not differ significantly between gen-
ders (Table VI). However, four men underwent open
surgical revascularization compared to zero women (P
.044). Limb-salvage rates were not significantly different
between genders (92.1%  4.4% in women vs 88.3% 
6.4% in men at 12 months and 85.0%  7.9% in women
vs 83.4%  7.7% in men at 24 months), as shown in Fig
3 (P  .985). Log-rank analysis of Kaplan-Meier curves
did not show significant differences in rates of overall
survival at 24 months between genders (59.8%  7.6%
for women and 68.0%  8.1% for men), as shown in Fig
4 (P  .351).
DISCUSSION
The United States is positioned to see a rise in the
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Fig 2. Secondary patency rates for infrageniculate inte
Twelve- and 24-month secondary patency rates for wom
76.0%  8.1% and 58.5%  10.8% in men (P  .028). B
Table VI. Rates of repeat intervention
Women Men
P valueNo. (%) No. (%)
1 repeat intervention 6 (9.5) 6 (12.2) .648
2 repeat interventions 3 (4.8) 6 (12.2) .174
3 repeat interventions 1 (1.6) 0 (0.0) .380
Bypass 0 (0.0) 4 (8.2) .044
Amputation 4 (6.3) 7 (14.3) .184
The boldface number represents statistical significance (P .05).average age of its population over the next 40 to 50 years, iarticularly due to the aging of the “baby-boomers.” Be-
ause lower extremity occlusive disease primarily afflicts
lderly populations, careful assessment of treatment modal-
ties for this debilitating disease will only become more
mportant in the coming years. Many sociologic and epide-
iologic studies have also documented that the majority of
he growing elderly population will be comprised of
omen (http://www.prcdc.org). Historically, there has
een a misconception that lower extremity occlusive arte-
ial disease does not affect women to the same extent as
en. These theories have some basis, as various reproduc-
ive and metabolic factors help to maintain an atheropro-
ective environment that may account for the delayed onset
f arterial disease seen in women.21-23 However, it has also
een established that once menopause occurs, this athero-
rotective environment disappears. Emerging evidence
rom multiple studies now suggests that the incidence of
rterial occlusive disease becomes equal between genders
uring the sixth and seventh decades of life, and some
urveys even report higher rates of lower extremity occlu-
ive disease in women compared to men.24-27
Women who are screened for PAD also tend to present
ith more asymptomatic disease than men, which may
ontribute toward an older age at treatment.28 However,
hen women do seek treatment, they present with signifi-
antly more advanced disease than men—a finding that has
een confirmed by our group’s recent studies on gender-
elated differences in lower extremity occlusive disease.4,19
ne hypothesis for this pattern is that when women do
resent to physicians with symptoms akin to lower extrem-
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Volume 57, Number 3 Tye et al 711osteoporosis or arthritis—problems commonly found in
this population.29,30 Another possible explanation is that
elderly women tend to be more socially isolated and have
lower income than men, thus making them less likely to
seek medical care.31
To our knowledge, this study is the first of its kind to
purely investigate the gender-related differences in endo-
vascular treatment of infrageniculate disease. Our findings
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cally challenging disease, male gender remained an inde-
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y Gallagher et al32 on gender differences in the endovas-
ular treatment of infrainguinal PAD has demonstrated
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March 2013712 Tye et alGallagher et al32 found that in patients with chronic limb
ischemia receiving percutaneous transluminal angio-
plasty (PTA) for tibial disease, women had superior
primary and secondary patency rates at all time points
when compared to men. In their study, there were no
differences between genders with respect to lesion
length, diameter, or TASC classification. Their patency
findings are consistent with those of our current study,
which includes both patients undergoing PTA only and
those undergoing PTA  stenting.
Although this study is the first to purely investigate the
role of gender on outcomes after infrageniculate endovas-
cular interventions, there exist a number of general studies
on tibial percutaneous interventions that include basic
comparisons between genders. In contrast to our current
study, themajority of these small, retrospective studies have
shown no gender differences in long-term outcomes after
either tibial PTA or cases of primary tibial stenting in their
analyses.16,17,33 Additionally, a meta-analysis conducted by
Romiti et al34 on the use of infrapopliteal angioplasty to
treat chronic critical limb ischemia in 30 studies found that
gender was not a significant predictor of patency or limb-
salvage rates. A notable finding from review of these studies
was a pattern of inferior patency rates compared to those in
our study (12-month primary patency of 58.1%  4.6%
reported by Romiti et al34 vs 69.7% 5.6% in our study and
12-month secondary patency of 68.2% 5.9% reported by
Romiti et al34 vs 84.1%  4.5% in our study). The reasons
for this difference are unclear. As suggested by others, there
is significant variability in techniques applied among the
literature, which may account for the variability seen in
outcomes. Additionally, as techniques improve over time,
reported results are expected to be better.17
Althoughmost of the existing literature on infragenicu-
late endovascular repair has shown equivalent gender out-
comes, the evidence is less clear for lower extremity open
repair. Many studies have demonstrated conflicting results
in patency and limb-salvage rates between genders after
open revascularization procedures.9-13 Despite this con-
flicting data, one consistent finding in the literature is that
women undergoing open revascularization experience an
increased frequency of wound complications. Furthermore,
female gender remains an independent risk factor for post-
operative wound and infectious complications even when
results are controlled for concomitant comorbidities. Rea-
sons for this discrepancy are not well understood but could
include differences between men and women in metabo-
lism, fat content, and fat distribution (particularly in the
upper thighs).
Endovascular repair may thus be a reasonable therapeu-
tic alternative that can minimize such complications in
women. In this current gender-focused analysis of patients
undergoing primary tibial interventions, there were no
differences between genders in periprocedural mortality
rates and wound complications. This finding is consistent
with a study conducted by our group in 2010 that exam-
ined risk factors for PAD and outcomes after open or
endovascular lower extremity arterial reconstructions (us- Sng a large discharge database from the three most popu-
ous US states providing gender data). In that report,
omen had significantly higher mortality and periproce-
ural complications when compared to men undergoing
pen reconstructions; however, the gender-related discrep-
ncy was notably diminished after endovascular proce-
ures.19
There are some notable differences between this cur-
ent gender analysis of percutaneous infrageniculate inter-
entions and our group’s previous gender study on percu-
aneous infrainguinal interventions. For one, in our
revious report, women undergoing infrainguinal interven-
ions were older than men.20 This age difference was not
tatistically significant in our current analysis, which dealt
nly with patients with more advanced (tibial) disease.
urthermore, our previous report showed that although
atency and limb salvage rates were similar in both genders,
omen requiredmore reinterventions tomaintain the same
econdary patency rate. In the current study, this difference
issipated as well.
There are certain limitations to this study; namely, the
etrospective nature of the study and the relatively small
umber of patients included in the study. Short follow-up
ime is also a potential limitation of this study. Nonetheless,
his the only existing study that is focused specifically on
ender-related differences in infrageniculate interventions
nd provides an analytical comparison of complications and
utcomes between men and women.
ONCLUSIONS
Percutaneous intervention may be an equally effective
r better treatment option in women with chronic limb
schemia and tibial disease when compared tomen.Women
n our study had superior primary and secondary patency
ates when compared to men after endovascular treatment
f infrapopliteal lesions, in addition to equivalent postop-
rative complication rates. Although larger studies with
onger follow-up times are required to further investigate
his treatment modality, our findings, in conjunction with
hose of previous articles, support the view that endovascu-
ar treatment may lessen the gap in gender-related treat-
ent outcomes and postoperative complications observed
n patients undergoing open arterial reconstructions.
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